Valantine Hannah
Director · CDNA, BBIO, PACB
As of 2026-09-16, Valantine Hannah has 40 Form 4 transactions on record across 3 companies — 27 in the trailing 12 months.
Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.
Pattern in the record: open-market sales filed in June in multiple years since 2025 — a recurring calendar cadence, more consistent with scheduled activity than a one-off decision.
Reconstructed holdings
Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.
Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.
Trades by company
Filing ledger
| Date | Company | Action | Shares @ price | Value | Ownership Δ | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-16 | CDNA | Sale | 28,679 @ $36.14 | $1.0M | −43.8% of holding | 36,786 | Form 4 |
| 2026-07-16 | CDNA | Sale | 100 @ $36.55 | $4K | −0.3% of holding | 36,686 | Form 4 |
| 2026-06-23 | BBIO | Sale | 2,196 @ $68.57 | $151K | −19.2% of holding | 9,259 | Form 4 |
| 2026-06-22 | BBIO | Sale | 2,808 @ $68.00 | $191K | −19.7% of holding | 11,455 | Form 4 |
| 2026-06-15 | CDNA | Sale | 12,103 @ $23.11 | $280K | −24.8% of holding | 36,686 | Form 4 |
| 2026-03-10 | BBIO | Sale | 8,671 @ $72.00 | $624K | −53.7% of holding | 7,465 | Form 4 |
| 2026-02-27 | BBIO | Sale | 14,584 @ $67.08 | $978K | −44.3% of holding | 18,365 | Form 4 |
| 2026-02-27 | BBIO | Sale | 10,900 @ $67.84 | $739K | −59.4% of holding | 7,465 | Form 4 |
| 2025-11-12 | BBIO | Sale | 25,484 @ $66.07 | $1.7M | −77.3% of holding | 7,465 | Form 4 |
| 2025-06-26 | BBIO | Sale | 1,891 @ $44.03 | $83K | −82.6% of holding | 398 | Form 4 |
| 2025-06-26 | BBIO | Sale | 1,542 @ $44.01 | $68K | −17.1% of holding | 7,465 | Form 4 |
| 2025-06-26 | BBIO | Sale | 876 @ $44.11 | $39K | −8.9% of holding | 9,007 | Form 4 |
| 2025-06-26 | BBIO | Sale | 398 @ $44.13 | $18K | −14.8% of holding | 2,289 | Form 4 |
| 2025-06-18 | CDNA | Sale | 10,570 @ $19.16 | $203K | −21.3% of holding | 38,994 | Form 4 |
| 2025-06-10 | BBIO | Sale | 4,292 @ $40.00 | $172K | −70.9% of holding | 1,764 | Form 4 |
| 2025-03-06 | BBIO | Sale | 12,875 @ $32.58 | $419K | −87.9% of holding | 1,764 | Form 4 |
24 award / exercise / gift records — not counted as purchases
| Date | Company | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|
| 2026-07-16 | CDNA | Option exercise | 16,048 | 60,340 | Form 4 |
| 2026-07-16 | CDNA | Option exercise | 7,606 | 44,292 | Form 4 |
| 2026-07-16 | CDNA | Option exercise | 5,125 | 65,465 | Form 4 |
| 2026-07-16 | CDNA | Option exercise | 7,606 | 0 | Form 4 |
| 2026-07-16 | CDNA | Option exercise | 16,048 | 0 | Form 4 |
| 2026-07-16 | CDNA | Option exercise | 5,125 | 24,011 | Form 4 |
| 2026-06-22 | BBIO | Option exercise | 2,808 | 14,263 | Form 4 |
| 2026-06-22 | BBIO | Award / grant | 5,277 | 5,277 | Form 4 |
| 2026-06-22 | BBIO | Option exercise | 2,808 | 5,617 | Form 4 |
| 2026-06-22 | BBIO | Award / grant | 3,990 | 11,455 | Form 4 |
| 2026-06-12 | CDNA | Award / grant | 9,795 | 48,789 | Form 4 |
| 2026-06-03 | PACB | Award / grant | 223,492 | 223,492 | Form 4 |
| 2026-03-10 | BBIO | Option exercise | 8,671 | 16,136 | Form 4 |
| 2026-03-10 | BBIO | Option exercise | 8,671 | 17,343 | Form 4 |
| 2026-02-27 | BBIO | Option exercise | 25,484 | 32,949 | Form 4 |
| 2026-02-27 | BBIO | Option exercise | 25,484 | 0 | Form 4 |
| 2025-11-12 | BBIO | Option exercise | 25,484 | 32,949 | Form 4 |
| 2025-11-12 | BBIO | Option exercise | 25,484 | 25,484 | Form 4 |
| 2025-06-13 | CDNA | Award / grant | 12,103 | 49,564 | Form 4 |
| 2025-06-10 | BBIO | Option exercise | 4,292 | 6,056 | Form 4 |
| 2025-06-10 | BBIO | Option exercise | 4,292 | 34,334 | Form 4 |
| 2025-06-04 | PACB | Award / grant | 65,000 | 65,000 | Form 4 |
| 2025-03-06 | BBIO | Option exercise | 12,875 | 14,639 | Form 4 |
| 2025-03-06 | BBIO | Option exercise | 12,875 | 38,626 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.